Atlas Trials

ML Score Prediction of Cardiotoxicity in Cancer Patients Receiving Anthracycline Chemotherapy or HER2-Targeted Therapies

Clinical trial NCT07191730 · RECRUITING

Trial details

NCT number
NCT07191730
Sponsor
University Hospital, Caen
Status
RECRUITING
Study type
OBSERVATIONAL
CardiotoxicityHeart FailureNeoplasmsBreast Neoplasms
Start date
2025-10-29
Primary completion
2028-03-01
Enrollment
600

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.